Profil
Alex Raeber worked as the Director of Global Research & Development at Thermo Fisher Scientific, Inc. He was also the Chief Scientific Officer & Executive Director at Benchmark Holdings Plc from 2018 to 2020.
Prior to that, he was the Head of Research & Development at Prionics AG from 2002 to 2011.
He worked as a Principal at both the University of California, Berkeley and the University of Zurich.
Raeber holds a doctorate from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Anciens postes connus de Alex Raeber
| Sociétés | Poste | Fin |
|---|---|---|
| BENCHMARK HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 31/07/2020 |
| THERMO FISHER SCIENTIFIC | Directeur Technique/Scientifique/R&D | - |
| University of Zurich | Corporate Officer/Principal | - |
| University of California, Berkeley | Corporate Officer/Principal | - |
Prionics AG
 Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Directeur Technique/Scientifique/R&D | - |
Formation de Alex Raeber
| Swiss Federal Institute of Technology | Graduate Degree |
| University of Zurich | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BENCHMARK HOLDINGS PLC | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Health Technology |